Principles of sentinel lymph node identification: background and clinical implications.

Area of Science:

• Oncology
• Surgical Oncology
• Dermatology

Background:

• Management of clinically negative regional lymph nodes in early-stage melanoma remains controversial.
• Elective node dissection (ELND) and therapeutic node dissection (TLND) are traditional approaches with varying outcomes.
• The concept of lymphatic spread and early detection of metastases is central to treatment decisions.

Purpose of the Study:

• To evaluate the role of intraoperative lymphatic mapping and sentinel lymphadenectomy (LM/SL) in the management of early-stage melanoma.
• To compare the effectiveness and morbidity of LM/SL with traditional lymph node dissection methods.
• To assess the accuracy of LM/SL in staging regional lymph nodes.

Main Methods:

• Intraoperative lymphatic mapping using lymphoscintigraphy and vital blue dye to identify the sentinel lymph node (SN).
• Sentinel lymphadenectomy (SLN) followed by completion lymph node dissection (CLND) for SN-positive cases.
• Pathological examination of SNs to detect micrometastases.

Main Results:

• LM/SL accurately identifies the SN, allowing precise staging of regional lymph nodes.
• Patients with tumor-negative SNs avoid the morbidity and cost of CLND.
• Studies validate the accuracy and low morbidity of LM/SL, though a learning phase is required.
• Randomized trials comparing ELND and TLND have not shown overall survival benefits, but suggest potential advantages for ELND in early metastases.

Conclusions:

• LM/SL is a minimally invasive technique for accurate staging of early-stage melanoma.
• It offers a more precise approach compared to ELND and TLND, potentially reducing unnecessary procedures.
• Further clinical trial results are needed to establish LM/SL as a replacement for traditional methods.